eye, with Scer\GAL4GMR.PF
Under control nutrition conditions, the adulthood-only expression of InRUAS.cHa under the combined control of Scer\GAL4C587 and Gal80[ts] does not lead to any significant changes in the number of escort cells in the germarium, as compared to controls.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4phm.PO does not significantly change the number of lipid droplets in the prothoracic gland cells of third instar larvae compared to controls.
Wild type males spend significantly more courtship time with females expressing InRScer\UAS.cHa under the control of Scer\GAL4αTub84B.Switch.PK (upon exposure to RU486), as compared to control females. The same effect on female attractiveness is seen when cuticular hydrocarbons from the aforementioned females are used to "perfume" same-age oenocyte-less flies.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4GMR.PF does not produce R8 photoreceptor cell phenotypes.
Overexpression of InRScer\UAS.cHa in fat body cell clones under the control of Scer\GAL4αTub84B.PP leads to an enormous fat body cell overgrowth phenotype. This is accompanied by a significant reduction in lipid droplet size compared with wild-type.
Fat body clones expressing InRScer\UAS.cHa under the control of Scer\GAL4αTub84B.PP show an increase in cell size.
Overexpression of InRScer\UAS.cHa under the control of Scer\GAL4GMR.PF results in eye hyperplasia.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4GMR.PF leads to an increase in ommatidia size.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4ptc-559.1 results in a weak but consistent expansion of the distance between wing veins L3 and L4.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4tim.Scer\UAS, dramatically increases sensitivity to oxidative stress. These flies die within 2 days of being challenged with 1mM paraquat. When treated with 0.05-0.1mM paraquat they survive up to 6 days, with the majority showing arrhythmic locomotor behavior.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4Switch1.106, increases sensitivity of behavioral rhythms to paraquat.
Expression of InRScer\UAS.cHa in border cells, driven by Scer\GAL4slbo.2.6 does not affect the formation of the egg chamber apical cap or the migration of the border cell cluster to the oocyte.
Pharate adults expressing InRScer\UAS.cHa under the control of Scer\GAL4phm.PO are 42% of the weight of controls when larvae have been raised in constant light.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4dpp.blk1 results in ectopic bristles and an excess of sensilla trichodea in the most proximal part of the coxa, ectopic bristles in the arista and third antennal segment, ectopic bristles in the capitellum and occasionally in the pedicellum of the haltere and ectopic thorn bristles in the female genitalia.
Cells in InRScer\UAS.cHa; Scer\GAL4Act5C.PP somatic clonesi n the larval fat body overgrow dramatically.
The eyes of InRScer\UAS.cHa; Scer\GAL4GMR.PF flies have massive overgrowth.
Flies that express InRScer\UAS.cHa under the control of both Scer\GAL4tin.cBa and Scer\GAL4Scer\UAS.cHa show a consistently low heart rate across all ages compared to wild-type flies. These flies show an increased rate of stress-induced heart failure at the age of one week compared to in wild type. The rate of this heart failure does increase with age, but at a markedly reduced magnitude compared to wild type. These effects are true for both male and female.
Almost all endogenous caspase activation is blocked in InRScer\UAS.cHa; Scer\GAL4GMR.PF eye discs of third instar larvae and 30 hours APF pupae. This is accompanied by an increase in photoreceptor differentiation at both of these stages.
Clones of cells expressing InRScer\UAS.cHa under the control of Scer\GAL4Act5C.PP in the gut, fat body, Malpighian tubules and epidermis are only slightly larger than control cells at the time of larval hatching. After several days of starvation on 20% sucrose, these cells are much larger than adjacent control cells and have a visibly increased DNA content. Gut and fat body cells expressing InRScer\UAS.cHa under the control of Scer\GAL4Act5C.PP continue to replicate their DNA for at least 2-3 days under starvation conditions. Expression of InRScer\UAS.cHa in third larval instar fat body cells under the control of Scer\GAL4Act5C.PP increases the opacity of the cytoplasm, thus promoting nutrient storage. The cytoplasm of the cells contains many more, but much smaller, lipid droplets than neighbouring control cells. Some fed animals expressing InRScer\UAS.cHa under the control of Scer\GAL4Adh.PF survive to the third larval instar and a few viable adults eclose. In contrast, expression of InRScer\UAS.cHa under the control of Scer\GAL4Adh.PF in starved animals results in first instar larvae dying within 3-4 days of hatching (control animals survive 8-9 days). Animals expressing InRScer\UAS.cHa under the control of Scer\GAL4Adh.PF feed poorly, often having no food in their gut, and frequently wander away from their food.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4Act5C.PP in clones results in an increase in cell size and an increase in clone area compared to controls.
InRScer\UAS.cHa when driven by Scer\GAL4ey.PH causes hyperproliferative outgrowth and an increase in cell size in the eye. A relatively normal ommatidial arrangement and architecture are retained.
When InRScer\UAS.cHa is driven by Scer\GAL4GMR.PF the flies have enlarged eyes due to an increase in cell number and cell size.
Expression of InRScer\UAS.cHa under the control of Scer\GAL4ey.PH results in lethality at 25oC and a dramatic increase in ommatidia number in escapers at room temperature.
When expression is driven by Scer\GAL4ey.PH at 25oC lethality results. At room temperature, a few flies survive with over proliferated eyes.
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, enhanceable by Pdk14ΔEP/Pdk1EP3091, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4αTub84B.PP has increased cell size | somatic clone phenotype, non-enhanceable by Ets97D613/Df(3R)ro80b
InRUAS.cHa, Scer\GAL4αTub84B.PP has increased cell size | somatic clone phenotype, suppressible by srlKG08646
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, suppressible by ImpL2EP5.66, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, suppressible | partially by ImpL2UAS.cHa, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, suppressible by ImpL2s.UAS, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4Act5C.PP has increased cell size | somatic clone phenotype, suppressible | partially by hepAct.UAS, Scer\GAL4Act5C.PP
InRUAS.cHa, Scer\GAL4GMR.PF has hyperplasia phenotype, suppressible by B4EP7-66
InRUAS.cHa, Scer\GAL4GMR.PF has hyperplasia phenotype, suppressible by B4UAS.cSa
InRUAS.cHa, Scer\GAL4en-e16E has lethal | embryonic stage phenotype, suppressible by B4UAS.cSa
InRUAS.cHa, Scer\GAL4GMR.PB has visible phenotype, suppressible by Df(3L)AC1
InRUAS.cHa, Scer\GAL4ey.PH has visible phenotype, suppressible by gigUAS.cTa/Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4ey.PH has lethal | heat sensitive phenotype, suppressible by gigUAS.cTa/Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, suppressible by Pdk14ΔEP/Pdk1EP3091, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, suppressible by Pk61C[+]/Pdk15ΔEP, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4ey.PH has abnormal size | adult stage phenotype, suppressible by PtenUAS.cHa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4αTub84B.PP has increased cell size | somatic clone phenotype, non-suppressible by Ets97D613/Df(3R)ro80b
InRUAS.cHa, Scer\GAL4GMR.PF has visible phenotype, non-suppressible by ImpL2MG2, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PB has visible phenotype, non-suppressible by Df(3L)AC1/Ilp2UAS.cBa, Scer\GAL4GMR.PB
InRUAS.cHa, Scer\GAL4ey.PH has lethal | heat sensitive phenotype, non-suppressible by Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4ey.PH has lethal | heat sensitive phenotype, non-suppressible by gigUAS.cTa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4ey.PH has visible phenotype, non-suppressible by Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4ey.PH has visible phenotype, non-suppressible by gigUAS.cTa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of abnormal neuroanatomy phenotype of Scer\GAL4GMR.PF, gogoScer\UAS.T1
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of abnormal neuroanatomy phenotype of Scer\GAL4GMR.PF, gogoDDD.UAS
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Pdk14ΔEP/Pdk1EP3091, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4αTub84B.PP has fat body | somatic clone phenotype, non-enhanceable by Ets97D613/Df(3R)ro80b
InRUAS.cHa, Scer\GAL4αTub84B.PP has fat body | somatic clone phenotype, suppressible by srlKG08646
InRUAS.cHa, Scer\GAL4αTub84B.PP has lipid droplet | somatic clone phenotype, suppressible by srlKG08646
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible by ImpL2EP5.66, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible | partially by ImpL2UAS.cHa, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible by ImpL2s.UAS, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has ommatidium phenotype, suppressible | partially by RpL8RNAi.UAS, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has ommatidium phenotype, suppressible | partially by Hsap\RPL8DN.UAS, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4Act5C.PP has embryonic/larval fat body | somatic clone phenotype, suppressible | partially by hepAct.UAS, Scer\GAL4Act5C.PP
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible by B4EP7-66
InRUAS.cHa, Scer\GAL4GMR.PB has eye phenotype, suppressible by Df(3L)AC1
InRUAS.cHa, Scer\GAL4ey.PH has ommatidium phenotype, suppressible by gigUAS.cTa/Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible by Pk61C[+]/Pdk15ΔEP, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, suppressible by Pdk14ΔEP/Pdk1EP3091, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4ey.PH has eye phenotype, suppressible by PtenUAS.cHa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4αTub84B.PP has fat body | somatic clone phenotype, non-suppressible by Ets97D613/Df(3R)ro80b
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, non-suppressible by ImpL2MG2, Scer\GAL4GMR.PF
InRUAS.cHa, Scer\GAL4GMR.PB has eye phenotype, non-suppressible by Df(3L)AC1/Ilp2UAS.cBa, Scer\GAL4GMR.PB
InRUAS.cHa, Scer\GAL4GMR.PF has eye phenotype, non-suppressible by Sps1k11320
InRUAS.cHa, Scer\GAL4ey.PH has ommatidium phenotype, non-suppressible by Tsc1UAS.cPa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4ey.PH has ommatidium phenotype, non-suppressible by gigUAS.cTa, Scer\GAL4ey.PH
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of photoreceptor cell R8 phenotype of Scer\GAL4GMR.PF, gogoScer\UAS.T1
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of medulla layer M1 phenotype of Scer\GAL4GMR.PF, gogoScer\UAS.T1
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of photoreceptor cell R8 phenotype of Scer\GAL4GMR.PF, gogoDDD.UAS
InRUAS.cHa, Scer\GAL4GMR.PF is an enhancer of medulla layer M1 phenotype of Scer\GAL4GMR.PF, gogoDDD.UAS
Expression of InRScer\UAS.cHa strongly enhances the R8 photoreceptor phenotype seen when gogoScer\UAS.T1 is expressed under the control of Scer\GAL4GMR.PF, resulting in an increase in the size of the blob-like structures seen in the medulla M1 layer. Premature axon stopping is also visible.
No R8 photoreceptor phenotypes are seen when gogoFFD.Scer\UAS and InRScer\UAS.cHa are co-expressed under the control of Scer\GAL4GMR.PF.
Expression of InRScer\UAS.cHa slightly enhances the R8 axon stopping phenotype seen when gogoDDD.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
The effects of Scer\GAL4αTub84B.PP>InRScer\UAS.cHa overexpression on cell growth and lipid droplet size in fat body cell clones are completely abrogated in a srlKG08646 mutant genetic background.
Ets97D613/Df(3R)ro80b does not significantly affect the increase in cell size seen in fat body clones expressing InRScer\UAS.cHa under the control of Scer\GAL4αTub84B.PP.
ImpL2EP5.66 suppresses the big eye phenotype resulting from the overexpression of InRScer\UAS.cHa driven by Scer\GAL4GMR.PF.
ImpL2MG2 fails to suppresses the big eye phenotype resulting from the overexpression of InRScer\UAS.cHa driven by Scer\GAL4GMR.PF.
ImpL2Scer\UAS.cHa partially suppresses the eye overgrowth resulting from the overexpression of InRScer\UAS.cHa driven by Scer\GAL4GMR.PF.
ImpL2s.Scer\UAS completely reverses the eye overgrowth resulting from the overexpression of InRScer\UAS.cHa driven by Scer\GAL4GMR.PF.
Expression of RpL8dsRNA.Scer\UAS partially suppresses the increase in ommatidia size seen when InRScer\UAS.cHa is expressed under the control of Scer\GAL4GMR.PF.
The distance between wing veins L3 and L4 is smaller than normal in flies co-expressing InRScer\UAS.cHa and TctpdsRNA.Scer\UAS under the control of Scer\GAL4ptc-559.1, resembling the phenotype seen in flies expressing TctpdsRNA.Scer\UAS alone under the control of Scer\GAL4ptc-559.1.
Overgrowth of cells in InRScer\UAS.cHa; Scer\GAL4Act5C.PP clones in the larval fat body is largely suppressed by hepAct.Scer\UAS.
The massive overgrowth of eyes seen in InRScer\UAS.cHa; Scer\GAL4GMR.PF flies is suppressed by B4EP7-66 or B4Scer\UAS.cSa. Embryonic lethality due to InRScer\UAS.cHa; Scer\GAL4en-e16E is also suppressed by B4Scer\UAS.cSa.
The addition of Df(3L)AC1 to InRScer\UAS.cHa, Scer\GAL4GMR.PB flies, suppresses the eye phenotype seen in these flies. The subsequent addition of Ilp2Scer\UAS.cBa reverts the suppression.
Coexpression of both gigScer\UAS.cTa and Tsc1Scer\UAS.cPa (but not either gigScer\UAS.cTa or Tsc1Scer\UAS.cPa alone) rescues the lethality and extra ommatidia phenotype of flies expressing InRScer\UAS.cHa under the control of Scer\GAL4ey.PH.
Eye size in animals expressing InRScer\UAS.cHa under the control of Scer\GAL4GMR.PF is restored almost to wild type by Pk61CEP3091/Pk61C4ΔEP, although eye roughness is increased.
Expression of Hsap\RPL8DN.Scer\UAS partially suppresses the increase in ommatidia size seen when InRScer\UAS.cHa is expressed under the control of Scer\GAL4GMR.PF.